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Background: Human labor is a complex series of cellular and molecular events that occur
at the materno-fetal and uterine levels. Many hypotheses have been proposed for the
initiation of human labor, one hypothesis suggests that maturation of the fetus releases a
signal in the amniotic fluid that will be transmitted to myometrium via the fetal membranes
and initiate uterine contractions. There is strong evidence that prostaglandins (PGs) play a
central role in initiation and progression of human labor.
Objectives: In this study we intended to investigate the expression of prostaglandin F
synthase and the prostaglandin transporter in the human fetal membranes and to explore
the relationship between cytokines and PGs in the mechanism of human labor.
Methods: We used fetal membranes obtained before labor at term and after spontaneous
labor at term or preterm to identify the changes in prostaglandin F synthase (AKR1B1) and
human prostaglandin transporter (SLCO2A1) proteins in relation to parturition. Using fetal
membranes explants we tested the effect of cytokines (interleukin-1 and tumor necrosis
factor alpha) on PG production and the concomitant changes in cyclooxygenase-2 (PTGS2),
AKR1B1 and SLCO2A1 expression.
Results: Expression of PTGS2 and AKR1B1 was upregulated in the fetal membranes in
association with term labor while SLCO2A1 was downregulated with advancing gestation
and during term labor. Before labor, IL-1 increased the expression of PTGS2, however
during labor TNF upregulated PTGS2 and AKR1B1 proteins.
Conclusions: The prostaglandin F synthase AKR1B1 is upregulated while prostaglandin
transporter is downregulated during term labor. The amnion is more responsive than
choriodecidua to stimulation with pro-inflammatory cytokines. The mechanisms of term
and preterm labor are different.
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INTRODUCTION
Labor is the result of strong uterine contractions that lead to
expulsion of the fetus to the extrauterine environment. The inci-
dence of preterm births is increasing and represents one of the
most challenging clinical problems all over the world. In the
United States the preterm birth rate increased from 9.5% in 1981
to 12.7% in 2005; the reported rates of preterm birth in other
developed countries and Europe range from 5 to 9% (Goldenberg
et al., 2008). At St Michael’s Hospital in Bristol the incidence
of preterm births is approximately 8% of all births (Yuan et al.,
2010).
The trigger of the onset of human labor is still unknown,
despite the impressive gains in clinical, physiological, and
biochemical knowledge. Some studies suggest that there are sev-
eral mechanisms for the onset of labor in women, such as
paracrine/autocrine events, fetal hormonal changes and overlap-
ping maternal/fetal factors (Weiss, 2000). Interaction between
several pathways might be essential to initiate the process of labor
and may include changes in estrogen and progesterone levels,
elevation of corticotropin-releasing hormone (CRH), increased
production of prostaglandins (PGs) and increased sensitivity
of the uterus to oxytocin (Navitsky et al., 2000). However, it
is not known whether labor is due to stimulation of uter-
ine contraction or loss of inhibitory mechanisms that keep
the uterus quiescent during pregnancy (Lopez Bernal et al.,
1995).
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There is strong evidence that PGs play a central role in ini-
tiation and progression of human labor. Generally it is believed
that the main sources for PGs found in the amniotic fluid
are the fetal membranes and decidua (Gibb, 1998; Olson and
Ammann, 2007). The maternal plasma level of PGF metabo-
lites increases with the onset of labor at term as well as preterm
(Sellers et al., 1981). Locally produced PGs can stimulate uterine
contractions by: (1) direct effect via their own receptors in the
myometrium (Senior et al., 1993), (2) increasing the sensitivity of
the myometrium to oxytocin through upregulation of oxytocin
receptors (OTR) (Chan and Chen, 1992), (3) upregulation of
myometrial gap junctions (Ivanisevic et al., 2001). Oxytocin and
PGs have a positive interaction which might be vital for coordi-
nated and efficient uterine contraction at the time of labor (Arias,
2000).
The PGs biosynthesis cascade involves different steps. First,
arachidonic acid (AA) is liberated from membrane phospho-
lipids principally through cytosolic phospholipase A2. AA is then
converted into prostaglandin H2 (PGH2), a relatively unstable
compound, by the action of prostaglandin H synthases (PTGS)
also known as cyclooxygenase enzymes and then into bioac-
tive PGs by terminal synthases such as TXA-, PGE-, and PGF-
synthases. PTGS enzymes have received most of the attention in
the literature; many studies have investigated their changes with
labor and the effect of blocking their actions in the manage-
ment of preterm labor (Fuentes et al., 1996; Slater et al., 1999;
Johnson et al., 2002; Stika et al., 2002). Terminal synthase path-
ways beyond PTGS, other than PGE synthases, have not been
well-investigated, although they might be excellent specific tar-
get in the prevention of preterm labor. There are three different
pathways for the synthesis of the uterotonic PGF2α: (1) from
PGH2 by PGH 9-, 11-endoperoxide reductase, (2) from PGD2 by
PGD 11-ketoreductase, (3) from PGE2 by PGE 9-ketoreductase
(Watanabe, 2002).
The main source of PGF2α is the direct conversion of PGH2 by
PGH2 9, 11-endoperoxide reductase; this activity is known as PGF
synthase (Watanabe et al., 1985). Only small amounts of PGF2α
are produced through reduction of PGE2 by carbonyl reductase
1. AKR1B1 has recently been identified as a functional PGF syn-
thase in the human uterus (Bresson et al., 2011) and based on its
molecular weight, amino acid sequence and substrate specificity it
has been assigned to the aldo-keto reductase family (Suzuki et al.,
1999). Although PGF2α is known to increase at the time of labor
and proved to induce myometrial contractions, to date there is
no information about PGF synthase expression and regulation in
human fetal membranes during pregnancy and labor (Helliwell
et al., 2004).
PGs are of lipid nature; however they diffuse poorly through
plasma membranes because they exist as charged species at phys-
iological pH (Schuster, 1998). The mechanism of PG transport
across the plasma membrane is not well-known, however differ-
ent models have been proposed such as simple diffusion, coun-
tercurrent transfer and carrier-mediated transport (Banu et al.,
2005). A prostaglandin transporter (SLCO2A1) is broadly dis-
tributed in human tissues and it is likely that it has a role in clear-
ance andmetabolism of endogenous prostanoids (Lu et al., 1996).
The functional uptake-carrier SLCO2A1 is a 12-transmembrane
protein which has high affinity for PGE2, PGF2α, and PGD2.
During the menstrual cycle the expression of SLCO2A1 in human
endometrium was found to be modulated at mRNA and pro-
tein levels, (Kang et al., 2005). To date there is very little
information regarding the distribution of prostaglandin F syn-
thase (AKR1B1) and prostaglandin transporter (SLCO2A1) in
the human fetal membranes in relation to term and preterm
labor. AKR1B1 and SLCO2A1 are more abundant in choriode-
cidua than in the amnion (Breuiller-Fouche et al., 2010; Phillips
et al., 2011).
Cytokines provide a major soluble intracellular signaling net-
work which allows biochemical cross-talk between the fetus and
the uterus. Moreover it has been proposed that regulation of
prostaglandin production by pro-inflammatory cytokines is an
important aspect of the mechanism of labor (Hansen et al., 1999).
Paracrine and autocrine interactions between pro-inflammatory
cytokines, especially interleukin-1 (IL-1) and tumor necrosis
factor-alpha (TNF), and PGs have been demonstrated in term
human decidua (Norwitz et al., 1992; Hansen et al., 1999). There
is strong evidence that fetal membranes are involved in the
process of human labor via release of PGs, however there are rel-
atively few studies comparing PG production from membranes
obtained before labor and those obtained after term and preterm
labor.
The purpose of this manuscript was to examine the distri-
bution of key enzymes for PG synthesis and transport in the
fetal membranes/decidua interface and to look for differences in
expression in relation to gestational age and the absence or pres-
ence of term and preterm labor. Moreover we intended to test the
effect of IL-1 and TNF on PG release, using an ex-vivo fetal mem-
branes model that preserves the anatomical integrity of the tis-
sues. We have conducted detailed experiments on the expression
of terminal PGF synthase and transporter in fetal membranes,
and assessed the effect of pro-inflammatory cytokines on their
protein expression levels. This study provides novel information
on the source of triggers of human labor and the roles of inflam-
matory cytokines in the mechanism of parturition that will help
in improving the management of preterm labor.
MATERIALS AND METHODS
COLLECTION OF TISSUES
The study was approved by the North Somerset and South Bristol
Research Ethics Committee. Placentas were collected from deliv-
ery suite in St Michael’s Hospital, Bristol, after women were
informed of the study and signed a consent form. All women
had singleton gestations and experienced spontaneous labor at
term (37–42 weeks gestation) or preterm (25–36 weeks), or had
an elective cesarean section before any signs of labor at term.
Patients admitted for elective preterm deliveries, due to placenta
praevia or preeclampsia, or induction of labor (IOL) at term were
also recruited (Table 1). The following groups of women were
included: Term not in labor (TNIL), preterm not in labor (PNIL),
spontaneous preterm labor (SPL), spontaneous term labor (STL),
and IOL. Patients with multiple pregnancies, prolonged rupture
of themembranes, or any signs of infection, including histological
chorioamnionitis, were excluded. All tissues were carried to the
laboratory in sterile cold saline and used immediately for tissue
Frontiers in Physiology | Clinical and Translational Physiology July 2014 | Volume 5 | Article 272 | 2
Alzamil et al. Terminal prostaglandin synthase in labor
Table 1 | Clinical details of patients whose samples were used in this study.
Mean (range) TNIL PNIL SPL STL IOL
Number (n) 7 9 8 9 9
Parity 1 (1–2) 0 1 (0–2) 1 (0–2) 0
Gestational age (weeks +days) 39 (39–40) 33+4 (27–36) 32+2 (25–36) 40 (39–40) 41+4(39–42)
Duration of labor (h:min) _ _ 5:21 (1:8–17:7) 7:15 (00:20–11:8) 9:26 (6:7–12:44)
Fetal weight (gm) 3790 (3300–4000) 1719 (585–2930) 1674 (780–2100) 3438 (2790–4000) 3713 (2870–4380)
TNIL, Term not in labor; PNIL, preterm not in labor; SPL, spontaneous preterm labor, STL, spontaneous term labor; and IOL, induction of labor. Values are means
with ranges in brackets.
culture, fixed for immunochemistry, or snap frozen and stored in
liquid nitrogen till used.
MATERIALS
Primary antibodies against AKR1B1 and SLCO2A1 were pro-
duced and characterized in house (Kang et al., 2005). PTGS2
antibodies were purchased from Santa Cruz Biotechnology (2145
Delaware Avenue Santa Cruz, CA, 95060 USA). RhoGDI was used
as a reference given its strong expression in human intrauter-
ine tissues (Lartey et al., 2006). Antibodies’ species of origin,
source, catalog number and dilutions for immunochemistry and
immunoblotting are summarized in Table 2.
The secondary antibodies used were horseradish peroxidase
conjugated (DAKO, Ely, UK). The rabbit anti-goat was used
at 1:1000 dilutions, swine anti-rabbit was used at 1: 1000 and
the rabbit anti mouse at 1:200. Cytokines (IL-1 and TNF-α,
BioSource Europe, Belgium) were added to membranes in the
explants to test their effects on PG production.
IMMUNOHISTOCHEMISTRY
Placental tissues were fixed with formalin for 24 h. Representative
blocks of each tissue were taken and processed in the
Histopathology Department at the Bristol Royal Infirmary
with a Leica JUNG TP 1050 Tissue processor (Leica,
Heidelberg, Germany) into paraffin wax and sectioned at 2μm
thickness.
The sections were dewaxed in Histo-Clear and passed through
alcohol. Endogenous peroxidase activity was blocked by 1%
hydrogen peroxide and then washed in running water. The anti-
gen was retrieved by boiling in a microwave after immersion in
500ml of citrate buffer solution. After washing with PBS 0.02%
Tween, the slides were blocked in a solution containing 1% bovine
serum albumin (BSA) plus 1% normal human serum and left at
room temperature for 1 h.
The primary antibodies were prepared in PBS solution, added
directly onto the sections and incubated overnight in a humid
chamber at 4◦C, then washed in PBS 0.02% Tween-20 three times
each for 5min. Secondary antibodies were added at room tem-
perature for at least 1 h, and then washed in the same way as the
primary antibodies. The slides were incubated with DAB solution
for 10min after which were dipped in water and then counter-
stained with Mayer’s hematoxylin for 30 s and washed with tap
water. The slides were dehydrated in graded alcohol solutions and
fixed in Histo-Clear, then mounted using mounting media and
covered with coverslips. The primary antibodies were excluded
Table 2 | Source and dilutions of primary antibodies used in
immunohistochemistry (IHC) and immunoblotting (IB).
Primary Species Source Dilution Dilution
antibody (Catalog umber) (IHC) (IB)
AKR1B1 Rabbit Gift from Dr. Fortier 1:100 1:2000
hPGT Rabbit Gift from Dr. Fortier 1:50 1:1000
PGDH Rabbit Gift from Dr. Fortier 1:100 1:100
PGES Rabbit Cayman (160140) 1:50 1:1000
COX-2 Goat Santa Cruz (sc-1745) 1:50 1:250
RhoGDI Goat Santa Cruz (sc-360) _ 1:20000
during staining of the slides used as a negative control for the
secondary antibodies.
Images were obtained by using a Leica DC300 camera (Leica,
Heidelberg Germany)mounted on anOlympus BX40microscope
(Melville, NY, USA).
IMMUNOBLOTTING
The tissues were homogenized on ice with cold RIPA buffer
(50mM Tris pH 7.5, 150mM NaCl, 1mM EDTA, 1% NP40,
0.5% Triton × 100 and 1% SDS) then centrifuged for 40min at
16,000×g and 4◦C. The supernatant was collected and the protein
concentration was determined by the bicinchoninic acid protein
assay kit (Thermo Scientific, Rockford, IL, USA).
Homogenized samples (50μg protein) were separated by SDS-
PAGE (12% gel) and transferred onto Immobilon membranes
(VWR international, Poole, UK). Membranes were blocked with
WesternBreeze (Invitrogen) blocking buffer for 1 h at room tem-
perature, and then incubated with diluted primary antibodies
overnight at 4◦C. After washing, the membranes were incu-
bated with horseradish peroxidase-conjugated secondary anti-
bodies (swine anti-rabbit, was used at 1: 5000 dilution and rabbit
antigoat at 1:20000) for 2 h at room temperature. Membranes
were then washed (three times for 5min) with washing buffer
and prepared for detection by chemiluminescence (Immobilon
Western Chemiluminescent HRP Substrate, Millipore, Billerica,
MA, US). PTGS2 protein was recognized by its antibody at 72 kDa
whereas AKR1B1 protein was recognized by the antibody at
37 kDa and SLCO2A1 protein at 72 kDa. All detected bands were
normalized to their individual RhoGDI bands, and then normal-
ized to the ratio of PTGS2 to RhoGDI of a pooled sample used in
all gels to eliminate the variations among different gels.
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FETAL MEMBRANE EXPLANTS
Membranes were manually cut into discs (18mm in diameter)
and were held using silicone rubber rings in the upper cham-
ber of a Transwell system (Costar) in which the original disc had
been removed. In this model the choriodecidua faces the upper
chamber, and the amnion faces the lower chamber. The mounted
explant was then placed in a 12-well tissue-culture plate (Costar)
(Zaga-Clavellina et al., 2007).
One milliliter of sterile Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum and
antibiotic-antimycotic solution (penicillin, 100U/ml; strepto-
mycin, 100μg/ml; amphotericin B, 0.25μg/ml) was added to
each chamber. The plates were incubated under 5% CO2 in 95%
air at 37◦C for 24 h to stabilize the tissues after manipulation.
CYTOKINE EXPOSURE IN EXPLANTS AND MEASUREMENT OF PGE2
AND PGF2α
Pro-inflammatory cytokines stimulate prostaglandin synthase
expression and PG release in human intrauterine tissues and we
wished to examine the effect of cytokine exposure on both the
maternal and fetal side of the fetal membranes on the rate of PGE2
and PGF2α production (Norwitz et al., 1992; Phillips et al., 2011).
The medium was changed to serum free DMEM, then explants
were exposed to 10 ng/ml of IL-1β, or TNF. We tested different
doses and we found that 10 ng/ml of IL-1β, or TNF were the
appropriate doses that gave maximum stimulation without toxic
effect on tissues. Each experiment included the following four
conditions in duplicate for each membrane: (1) control mem-
branes in which only medium was added to both compartments,
(2) IL-1β, or TNF added to upper compartment (choriodecidua)
only, (3) IL-1β, or TNF added to lower compartment (amnion)
only, (4) IL-1β, or TNF added to both upper and lower compart-
ments simultaneously. The media on both sides were collected
after 6 h of stimulation and frozen at −80◦C for prostaglandin
assays. PGE2 and PGF2α were measured in collected media using
the ELISA technique. Incubation of the tissues for longer than
6 h did not show a further significant increase in prostaglandin
production.
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) OF
PROSTAGLANDINS
Measurement of PGE2 and PGF2α was performed using an ELISA
technique in which acetylcholinesterase-linked PG tracers were
used as described previously (Asselin et al., 1996). Rabbit anti-
PGE2 (kindly provided by Dr. T. G. Kennedy, University of
Western Ontario, Ontario, ON, Canada) and sheep anti-PGF2α
(BioQuant, Ann Arbor, MI, USA) were used as selective antibod-
ies. The inter- and intra-assay coefficients of variation (n = 12)
were 16 and 10%, respectively. Briefly, 50μl of collected culture
mediumwas placed in a 96-well plate coated with goat anti-rabbit
(PGE2) or rabbit anti-sheep (PGF2α) secondary antibody. A vol-
ume of 50μl from each the tracer and the respective primary
antibody was added to each sample after which the samples were
incubated overnight at room temperature. After washing each
well, 200μl of Ellman’s reagent (69mM acetylthiocholine iodide;
Sigma A5751, 5 g) and 54mM5,5′-dithiobis (2-nitrobenzoic acid;
Sigma D8130, 5 g) dissolved in 10mM phosphate buffer pH 7.4
was added. The plate was incubated on a shaker in the dark
at room temperature, the reactions between the bound enzyme
tracer and the Ellman’s reagent yield a yellow color that can be
measured with a photometric plate reader. A standard curve was
used ranging from 39 to 5000 pg/ml PG.
STATISTICAL METHODS
The data was analyzed with SAS statistical software version 9.1.3.
(SAS Institute Inc., Cary, NC, USA). The groups were analyzed
separately, using Two-Way ANOVAs for each group. Pairwise
comparisons were made between the control mean and each of
the 9 treatment means; multiple comparisons were calculated
using Dunnett’s procedure.
RESULTS
LOCALIZATION OF PGF SYNTHASE AND PG TRANSPORTER IN
INTRAUTERINE TISSUES AT TERM
AKR1B1 and SLCO2A1 proteins were clearly expressed in decid-
ual cells (Figures 1A–L). In decidual cytoplasm there was uneven
distribution of AKR1B1 protein (Figure 1A) while the surround-
ing connective tissue appeared negative (Figure 1D). AKR1B1
protein was identified in the chorionic villi, in which the stain-
ing was strong in the cytoplasm of syncytiotrophoblasts while
cytotrophoblasts and villous stroma were negative (Figure 1E).
The SLCO2A1 protein was localized in decidual cytoplasm with
no staining in the connective tissue (Figure 1G). The syncytiotro-
phoblasts in the chorionic villi showed weak staining in their
cytoplasm and the cytotrophoblasts did not show any staining
with SLCO2A1 antibodies (Figure 1H).
Staining with PTGS2 antibody was found to be strongly
positive in the cytoplasm of some large decidual cells while
smaller cells showed weak staining; connective tissue of decidua
basalis showed no staining (Figure 1J). In the villi PTGS2 protein
was localized in the cytoplasm, in the outer layer (syncytiotro-
phoblast) staining was intense, while the inner layer of the villi
(cytotrophoblast) showed weak staining. Less intense staining was
observed in the core of the villi (Figure 1K).
In the fetal membranes AKR1B1 was highly expressed in the
chorion compared to decidua and there was no expression of this
protein in the amnion while a poor staining was detected in the
mesenchymal layer of the amnion (Figure 1F). The intensity of
the staining with SLCO2A1 antibody was equal in the two layers
of the fetal membranes and decidua parietals (Figure 1I).
All layers of the membranes and decidua parietals stained
strongly positive with PTGS2 antibody, the staining was also
observed in the mesenchymal layer of the amnion (Figure 1L).
EFFECT OF LABOR ON THE EXPRESSION OF PGF SYNTHASE AND PG
TRANSPORTER IN THE FETAL MEMBRANES
Using immunoblotting we found an increase in the expression of
AKR1B1 protein in fetal membranes collected after term labor
whether spontaneous or induced. However, preterm labor was
not associated with an increase in the level of AKR1B1 pro-
tein (Figure 2). By contrast, SLCO2A1 protein was significantly
decreased with advancing gestation with no changes in associa-
tion with labor at term or preterm (Figure 2). The increase in
AKR1B1 in the STL group and the apparent decrease in SPL
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FIGURE 1 | Immunohistochemistry staining of term decidua basalis (A),
chorionic villi (B) and fetal membranes (C) with AKR1B1 antibody (D–F),
SLCO2A1 antibody (G–I), and PTGS2 antibody (J–L). Primary antibodies
were omitted in (A–C) which served as controls. DC, decidual cells; Syn,
syncytiotrophoblast; Cyt, cytotrophoblast; IVS, intervillous space; De, decidua
parietalis; Ch, chorion; and A, amnion. Bar = 100μm.
reflected similar changes in PTGS2 protein expression in the same
samples (data not shown).
EFFECT OF CYTOKINES ON PG PRODUCTION IN THE FETAL
MEMBRANES
Exposure of the fetal side to IL-1β in all our tissues signifi-
cantly increased PGF2α and PGE2 production from the fetal side
(Figure 3) and this was associated with a significant increase in
PTGS2 protein expression. At term, before the onset of labor, TNF
had a significant stimulatory effect on PGF2α production from
the fetal side when added to both sides of the membrane at the
same time. This effect was associated with a significant increase
in AKR1B1 expression in the TNIL group, but not in the STL and
SPL groups (Figure 4).
DISCUSSION
To our knowledge this is the first study to compare the
level of protein expression of the PGF synthase AKR1B1 and
the PG transporter SLCO2A1 in fetal membranes of non-
laboring and laboring women at term and preterm. We have
found that expression of PTGS2 and AKR1B1 is increased in
fetal membranes at term labor, whereas SLCO2A1 decreases
with advancing gestation and term labor. Prior to labor, IL-1
enhances the expression of PTGS2; while in labor TNF stimu-
lates the expression of PTGS2 and AKR1B1. During term labor
AKR1B1 is upregulated with a concurrent downregulation of
the prostaglandin transporter SLCO2A1. IL-1 and TNF have a
stronger stimulatory effect on PG release in the amnion than in
choriodecidua.
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FIGURE 2 | Expression of AKR1B1 and SLCO2A1 protein in the fetal
membranes in association with term and preterm labor compared to
not in labor. TNIL, term not in labor; PNIL, preterm not in labor; SPL,
spontaneous preterm labor; STL, spontaneous term labor; IOL, induction of
labor. Westerns are representative of immunoblots prepared from fetal
membranes collected immediately after delivery, ∗∗p < 0.005.
The fetal membranes are in close contact with the uterine
decidua in an area estimated to be around 2000 cm2 and they
are thought to have a central role in the process of human labor
through paracrine effects on uterine activation (Myatt and Sun,
2010; Prince et al., 2014). It has been suggested that fetal mem-
branes play a part in maintaining uterine quiescence by releas-
ing putative inhibitors of spontaneous and oxytocin-induced
uterine contractions (Carvajal et al., 2006). Any disturbance of
FIGURE 3 | Effect of IL-1β on PGE2 and PGF2α production from the fetal
side of membranes. C, control; M, maternal side exposure; F, fetal side
exposure; and M&F, exposure to maternal and fetal sides; TNIL, term not in
labor; STL, spontaneous term labor; SPL, spontaneous preterm labor. The
bars represent the mean ± SD; n = 4, ∗p < 0.05 and ∗∗p < 0.005.
membrane integrity by amniotomy or membrane sweeping is
known to be associated with a rapid increase in prostaglandin
production followed by initiation of labor (Mitchell et al., 1977).
Recently it has been proposed that the fetal membranes are
involved in a positive feedback loop that stimulates the release
of biologically active glucocorticoids and PGs which eventu-
ally lead to maturation of fetal organs and initiation of labor
(Myatt and Sun, 2010).
In this paper we have described the localization of the pro-
teins involved in PGF2α synthesis and transport in intrauterine
tissues. Our findings show that in fetal membranes PTGS2 protein
is highly expressed in the amnion, chorion and adjacent decidua
while AKR1B1 expression is highest in the chorion and is absent
in the amnion. The co-localization of PTGS2 and AKR1B1 in the
chorion and adjacent decidua indicate that PGF2α production at
this site is important for initiation of human labor. In addition
we have demonstrated that SLCO2A1 protein is expressed in the
amnion and chorion as well as the decidua. Our observations
are in line with a recent study which confirmed that human fetal
membranes possess autoregulatory mechanisms for PGF2αaction
(Breuiller-Fouche et al., 2010). The same study reported that in
both layers of the fetal membranes the expression of AKR1B1
was higher than that of another PGF synthase, namely AKR1C3
(Breuiller-Fouche et al., 2010).
The current study shows increased density of AKR1B1 protein
in fetal membranes with term labor and a decrease of SLCO2A1
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FIGURE 4 | Effect of TNF-α on expression of AKR1B1 protein in the
fetal membranes and the associated changes in PGF2α production
from fetal side of membranes. C, control; M, maternal side exposure; F,
fetal side exposure; and M&F, maternal and fetal sides exposure. TNIL,
term not in labor; STL, spontaneous term labor; SPL, spontaneous preterm
labor. The bars represent the mean ± SD; n = 4, ∗p < 0.05.
protein with advancing gestation. SLCO2A1 contributes to the
uptake of PG by the cells for their degradation and clearance
(Kang et al., 2006) and its downregulation can lead to accu-
mulation of PGs at their site of action. The downregulation of
SLCO2A1 expression combined with upregulation of AKR1B1
protein in fetal membranes could have a synergetic effect to
increase the levels of local PGF2α during term labor. Compared
to the recent findings of low expression of AKR1B1 in human
myometrium (Phillips et al., 2011) our study demonstrates that
AKR1B1 is highly expressed in the fetal membranes especially in
association with term labor. Recently it has been suggested that
AKR1B1 may act as a multifunctional enzyme in the fetal mem-
branes through mediating inactivation of progesterone besides
generation of PGF2α (Breuiller-Fouche et al., 2010).
Our findings have shown an increase in AKR1B1 in fetal mem-
branes after IOL which suggests that this change is part of the
final steps in the process of labor at term. However, preterm labor
occurs with low levels of AKR1B1; this may reflect differences in
gestational maturity of the fetal membranes and increased sensi-
tivity of the myometrium to potential triggers of labor such as
PGF2α. We have also observed that PTGS2 protein expression
was significantly increased in fetal membranes in association with
term but not preterm labor, which supports the assumption that
the mechanism of spontaneous labor is at least partially different
in term and preterm groups.
Late pregnancy is a complex equilibrium between physio-
logical pathways that maintain uterine quiescence and poten-
tial disruption by inflammatory pathways probably triggered by
infection although many questions remain (Prince et al., 2014).
IL-1 and TNF are key mediators of inflammation and immune
responses and their potential role in labor has been emphasized
earlier (Norwitz et al., 1992; Hansen et al., 1999). We have con-
firmed that IL-1β stimulates PGF2α and PGE2 production from
fetal membranes before and after the onset of labor; this implies
that IL-1β is an important factor for initiation as well as estab-
lishment of human parturition. A recent study reported that the
increase in production of PGF2α and PGE2 after stimulation
of human endometrial cells with IL-1β can be reduced in the
presence of FP receptor antagonists, indicating that PGF2α was
able to stimulate its own and PGE2 productions (Bresson et al.,
2012). Other workers found that IL-1β was a potent stimulator
of PGE2 production from term intact fetal membranes collected
before the onset of labor (Brown et al., 1998). Previous studies
reported that IL-1β increased in the amniotic fluid of sponta-
neous term (Romero et al., 1992) as well as preterm labor (Baud
et al., 1999). Another group of investigators reported that IL-1β
increased oxytocin release from human decidua by a mechanism
that involved production of PGs through PTGS2 upregulation
(Friebe-Hoffmann et al., 2007). This local interaction between
PGs and oxytocin may facilitate the progress of labor.
We have observed a moderate effect of TNF to initiate term
labor through upregulation of AKR1B1 and stimulation of PGF2α
production. In line with our results, Sadowsky and colleagues,
using intra-amniotic infusions of pro-inflammatory cytokines
demonstrated that IL-1β was more effective than TNF in initi-
ating preterm labor in rhesus monkeys (Sadowsky et al., 2006).
Surprisingly, we observed that TNF inhibits AKR1B1 protein
expression in membranes collected after labor when added to
both sides in term and maternal side in preterm. This inhibition
might be an important mechanism to control the level of PGF2α
during labor since high levels of PGF2α might be harmful to the
fetus if it triggered tetanic contractions.
Interestingly, in the current study we noticed that although
the exposure of the fetal side of term fetal membranes to IL-1β
stimulated PGF2α production, the simultaneous exposure of fetal
and maternal sides to IL-1β had no effect. Osman and cowork-
ers reported that although the expression of IL-1β mRNA did not
change in the choriodecidua (maternal side), its level was found
to be significantly higher in the amnion (fetal side) after the onset
of term labor (Osman et al., 2003). By contrast, the exposure of
preterm membranes to IL-1β from both sides had an accumu-
lating stimulatory effect for PGF2α production providing further
evidence for different mechanisms for term and preterm labor.
We observed that during term and preterm labor the amnion
became more responsive to the stimulatory effect of IL-1β and
released high levels of PGE2 when compared to not in labormem-
branes. This observation might indicate that the process of term
and preterm labor involves upregulation of IL-1β receptors in the
amnion.
Our findings suggest that the sequence of IL-1β effects in the
fetal membranes is to stimulate PTGS2 expression by autocrine
or paracrine action in choriodecidua, followed by paracrine
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stimulation of PG release in the amnion. In this regard Zaga and
coworkers reported that IL-1β secretion to the amniotic compart-
ment was observed only when choriodecidua and amnion were
together. On the other hand when both tissues were mechanically
separated, only choriodecidua secreted IL-1β (Zaga et al., 2004).
A previous study demonstrated that PTGS2 mRNA progres-
sively accumulates in the membranes before and during labor
causing a steady rise in PG biosynthetic capacity when translated
into active protein (Johnson et al., 2002). Our findings imply that
IL-1β released by fetal tissues, might be one of the factors that can
stimulate PTGS2 expression via its action on the amnion. On the
other hand, concurrent exposure of maternal and fetal sides of
the membrane to TNF upregulated AKR1B1 protein in the mem-
branes of non-laboring women, which explains the stimulatory
effect of this cytokine on PGF2α production.
The data in the current study support the hypothesis that
fetal membranes, through their response to stimulation by pro-
inflammatory cytokines and release of PGs, play an important
role in the process of human labor. Pro-inflammatory cytokines
released by fetal tissues could be important triggering factors that
need to receive focused attention in future research in an attempt
to find more effective targets for the management of preterm
labor.
In conclusion, advancing gestation is associated with accu-
mulation of PTGS2 protein as well as a decrease of SLCO2A1
protein that helps to prepare the fetal membranes to respond to
stimulatory factor(s) in labor. TNF acts during labor to increase
AKR1B1 protein level leading to increased PGF2α production. We
can speculate that the trigger of labor is probably coming from
the fetal side of the membranes when IL-1β is released and leads
to synthesis of PTGS2 protein which starts labor by increasing PG
production. Increased PGE2 and PGF2α production as reflected
by rising amniotic fluid concentrations may promote membrane
rupture and initiate uterine contractions.
Parturition must be the result of maturational events in the
fetus, probably involving the hypothalamic pituitary adrenal axis,
increased sensitivity of the uterus to stimulatory agonists and loss
of inhibitory mechanisms in myometrial smooth muscle (Lopez
Bernal et al., 1995; Li et al., 2014). In a minority of cases inflam-
matory infiltration of the fetal membranes and decidua may
trigger premature labor, however many women go into preterm
labor without signs of infection or inflammation and other mech-
anisms may be involved. In this regard it is interesting to note that
oxytocin stimulates PTGS2 expression through a calcium depen-
dent NFAT (nuclear factor of activated T cells) signaling pathway
(Pont et al., 2012). Our findings also indicate that themechanisms
of spontaneous labor are different at term and preterm. Further
research into the paracrine and autocrine effects of cytokines and
PGs in the decidua/fetal membranes area is required to eluci-
date the biochemical and physiological events underlying these
mechanisms.
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